284 related articles for article (PubMed ID: 22178517)
1. Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant.
Amorim JH; Diniz MO; Cariri FA; Rodrigues JF; Bizerra RS; Gonçalves AJ; de Barcelos Alves AM; de Souza Ferreira LC
Vaccine; 2012 Jan; 30(5):837-45. PubMed ID: 22178517
[TBL] [Abstract][Full Text] [Related]
2. Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge.
Henriques HR; Rampazo EV; Gonçalves AJ; Vicentin EC; Amorim JH; Panatieri RH; Amorim KN; Yamamoto MM; Ferreira LC; Alves AM; Boscardin SB
PLoS Negl Trop Dis; 2013; 7(7):e2330. PubMed ID: 23875054
[TBL] [Abstract][Full Text] [Related]
3. Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice.
Lu H; Xu XF; Gao N; Fan DY; Wang J; An J
Mol Immunol; 2013 Jun; 54(2):109-14. PubMed ID: 23270684
[TBL] [Abstract][Full Text] [Related]
4. Transcutaneous Administration of Dengue Vaccines.
Andreata-Santos R; Alves RPDS; Pereira SA; Pereira LR; Freitas CL; Pereira SS; Venceslau-Carvalho AA; Castro-Amarante MF; Favaro MTP; Mathias-Santos C; Amorim JH; Ferreira LCS
Viruses; 2020 May; 12(5):. PubMed ID: 32384822
[TBL] [Abstract][Full Text] [Related]
5. T Cell Responses Induced by DNA Vaccines Based on the DENV2 E and NS1 Proteins in Mice: Importance in Protection and Immunodominant Epitope Identification.
Pinto PBA; Assis ML; Vallochi AL; Pacheco AR; Lima LM; Quaresma KRL; Pereira BAS; Costa SM; Alves AMB
Front Immunol; 2019; 10():1522. PubMed ID: 31333657
[TBL] [Abstract][Full Text] [Related]
6. Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.
Hertz T; Beatty PR; MacMillen Z; Killingbeck SS; Wang C; Harris E
J Immunol; 2017 May; 198(10):4025-4035. PubMed ID: 28381638
[TBL] [Abstract][Full Text] [Related]
7. Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen.
Alves RPDS; Pereira LR; Fabris DLN; Salvador FS; Santos RA; Zanotto PMA; Romano CM; Amorim JH; Ferreira LCS
Clin Vaccine Immunol; 2016 Jun; 23(6):460-469. PubMed ID: 27030586
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in nontoxic Escherichia coli heat-labile toxin and its derivative adjuvants.
Ma Y
Expert Rev Vaccines; 2016 Nov; 15(11):1361-1371. PubMed ID: 27118519
[TBL] [Abstract][Full Text] [Related]
9. Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design.
Ramírez R; Falcón R; Izquierdo A; García A; Alvarez M; Pérez AB; Soto Y; Muné M; da Silva EM; Ortega O; Mohana-Borges R; Guzmán MG
Virus Genes; 2014 Oct; 49(2):185-95. PubMed ID: 24854144
[TBL] [Abstract][Full Text] [Related]
10. Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection.
Tumpey TM; Renshaw M; Clements JD; Katz JM
J Virol; 2001 Jun; 75(11):5141-50. PubMed ID: 11333895
[TBL] [Abstract][Full Text] [Related]
11. The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigens.
Leach S; Clements JD; Kaim J; Lundgren A
PLoS One; 2012; 7(12):e51718. PubMed ID: 23284753
[TBL] [Abstract][Full Text] [Related]
12. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
[TBL] [Abstract][Full Text] [Related]
13. The A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigens.
Norton EB; Lawson LB; Mahdi Z; Freytag LC; Clements JD
Infect Immun; 2012 Jul; 80(7):2426-35. PubMed ID: 22526674
[TBL] [Abstract][Full Text] [Related]
14. LT-IIb(T13I), a non-toxic type II heat-labile enterotoxin, augments the capacity of a ricin toxin subunit vaccine to evoke neutralizing antibodies and protective immunity.
Greene CJ; Chadwick CM; Mandell LM; Hu JC; O'Hara JM; Brey RN; Mantis NJ; Connell TD
PLoS One; 2013; 8(8):e69678. PubMed ID: 23936344
[TBL] [Abstract][Full Text] [Related]
15. Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity.
Ryan EJ; McNeela E; Pizza M; Rappuoli R; O'Neill L; Mills KH
J Immunol; 2000 Nov; 165(10):5750-9. PubMed ID: 11067933
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant.
Norton EB; Lawson LB; Freytag LC; Clements JD
Clin Vaccine Immunol; 2011 Apr; 18(4):546-51. PubMed ID: 21288994
[TBL] [Abstract][Full Text] [Related]
17. Combination of E- and NS1-Derived DNA Vaccines: The Immune Response and Protection Elicited in Mice against DENV2.
Pinto PBA; Barros TAC; Lima LM; Pacheco AR; Assis ML; Pereira BAS; Gonçalves AJS; Azevedo AS; Neves-Ferreira AGC; Costa SM; Alves AMB
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891431
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin.
Luo Q; Vickers TJ; Fleckenstein JM
Clin Vaccine Immunol; 2016 Jul; 23(7):628-37. PubMed ID: 27226279
[TBL] [Abstract][Full Text] [Related]
19. GM1 binding-deficient exotoxin is a potent noninflammatory broad spectrum intradermal immunoadjuvant.
Zoeteweij JP; Epperson DE; Porter JD; Zhang CX; Frolova OY; Constantinides AP; Fuhrmann SR; El-Amine M; Tian JH; Ellingsworth LR; Glenn GM
J Immunol; 2006 Jul; 177(2):1197-207. PubMed ID: 16818778
[TBL] [Abstract][Full Text] [Related]
20. Use of a Recombinant Gamma-2 Herpesvirus Vaccine Vector against Dengue Virus in Rhesus Monkeys.
Bischof GF; Magnani DM; Ricciardi M; Shin YC; Domingues A; Bailey VK; Gonzalez-Nieto L; Rakasz EG; Watkins DI; Desrosiers RC
J Virol; 2017 Aug; 91(16):. PubMed ID: 28592531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
